DENVER, April 02, 2019 (GLOBE NEWSWIRE) -- United Cannabis Corporation (OTCQB: CNAB) (the “Company” or “United
Cannabis”) today announced that it has entered into a Partnership with John Easterling, environmentalist and founder of the
multi-million dollar Amazon Herb Company, to create and produce formulations that combine the health benefits of cannabinoids with
botanicals from the Amazonian Rainforest.
Mr. Easterling turned a fascination with South America into a lifelong pursuit. His first years were spent
seeking and trading tribal artifacts on behalf of museums and collectors, when a long bout with hepatitis and Rocky Mountain
spotted fever left him gravely ill. He soon found himself under the care of the Shipibo tribe in the Amazon rainforest, who gave
him a homeopathic herbal tea that cured him within days. Since that time, Mr. Easterling has been dedicated to the exploration and
preservation of the rainforest.
Mr. Easterling co-founded Amazon Herb Company to develop and market healing remedies that rely on the plants of
the rainforest on a socially responsible basis. In 2012, it merged with the global wellness company TriVita, based in Arizona.
Mr. Easterling will use his expertise to develop proprietary formulations that leverage the health benefits
found in the plants of the rainforest with United Cannabis’ patented cannabinoid formulations and delivery mechanisms to create
medicines for a variety of conditions. He will receive a royalty on the sales derived from products created through the
partnership.
Earnest Blackmon, Chief Executive Officer of United Cannabis, commented on the announcement, “We’ve built United
Cannabis on the philosophy that plants offer significant medical benefit, a view that John shares. His knowledge and insight
regarding the opportunities for synergies between rainforest botanicals and cannabinoids will be invaluable as we seek to develop
new medical therapies to complement our Prana Bio Nutrient Medicinals and Industrial Hemp product lines.”
Mr. Easterling added, “The Amazon is home to the largest and most bio-diverse tropical rainforest in the world.
The plants found there have some of the most powerful analgesic, antioxidant, anti-inflammatory and detoxifying properties
available, and I have spent my life creating products that bring those benefits to patients across the globe. I believe that
cannabinoids are making equally powerful contributions to our general health and wellness, and I look forward to working with the
team at United Cannabis to create formulations that leverage the benefits of both of these resources.”
About United Cannabis Corporation
United Cannabis Corporation is a biotechnology company dedicated to the development of phyto-therapeutic based
products supported by patented technologies for the pharmaceutical, medical, and industrial markets. The Company has long advocated
the application of cannabinoids for medical applications and is building a platform for designing targeted therapies to increase
the quality of life for patients around the world. Most of the Company’s products are patent protected first in class medicines
with applications to a global market. United Cannabis trades on the OTCQB under the symbol CNAB.
For further information, please visit www.unitedcannabis.us.
Contact: Staff@UnitedCannabis.us
Phone: 303-386-7321
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175
under the Securities Act of 1933, are subject to Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe
harbors created by those rules. All statements, other than statements of fact, included in this release, including, without
limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve
risks and uncertainties. There can be no assurance that such statements will prove to be accurate and future results and events
could differ materially from those anticipated in such statements.